The efficacy of fluticasone propionate nebulizer therapy in children with laryngotracheitis

Authors

  • Лариса Михайлівна Станіславчук M. I. Pyrogov Vinnytsya National Medical University 56 Pirogov str., Vinnytsya, Ukraine, 21018, Ukraine

DOI:

https://doi.org/10.15587/2313-8416.2015.48203

Keywords:

laryngotracheitis, laryngotracheobronchitis, children, fluticasone propionate, nebulizer therapy, glucocorticoids

Abstract

Objective. To determine the efficacy of fluticasone propionate (FP) nebulizer therapy in children with laryngotracheitis (LT)

Methods. There were children with LT and laryngotracheobronchitis (LTB) aged 0–13 years under observation. 97 children with an initial Westley score 1-5 received nebulized FP 0.5 mg every 6 hours up to no stridor. 104 controls matched by age, sex and severity received systemic glucocorticoids intramuscularly or intravenously. The efficacy of treatment was assessed with a total dose of glucocorticoids used and with duration of treatment up to Westley score 0. We compared effectiveness of therapy in both groups

Results. FP treatment was associated with a significant improvement in symptoms in patients with mild LT and LTB (Westley score 1-3) at 6 hours, in patients with moderate LT and LTB (Westley score 4-5) – at 12 hours.

The improvement was slower in case of LTB than in LT. A total dose of FP used in children with mild LT and LTB up to Westley score 0 was 0,68±0,42 mg, in children with moderate LT and LTB – 1,1±0,81 mg versus 3,23±3,69 mg / kg and 4,43±3,77 mg / kg respectively as to prednisolone equivalent doses of systemic glucocorticoids in controls. The duration of treatment up to Westley score 0 was shorter in children treated with FP compared to controls

Conclusion. Nebulized FP is effective in relieving the symptoms of mild to moderate LT and LTB

Author Biography

Лариса Михайлівна Станіславчук, M. I. Pyrogov Vinnytsya National Medical University 56 Pirogov str., Vinnytsya, Ukraine, 21018

Candidate of medical science, associate professor

Department Pediatric Infectious Diseases

References

Cherry, J. D. (2008). Clinical practice. Croup. New England Journal of Medicineed, 358 (4), 384–391. doi: 10.1056/nejmcp072022

Westley, C. R., Cotton, E. K., Brooks, J. G. (1978). Nebulized Racemic Epinephrine by IPPB for the Treatment of Croup. American Journal of Diseases of Children, 132 (5), 484–487. doi: 10.1001/archpedi.1978.02120300044008

Mazza, D., Wilkinson, F., Turner, T., Harris, C. (2008). Health for Kids Guideline Development Group. Evidence based guideline for the management of croup. Aust Fam Physician, 37 (6), 14–20.

Bjornson, C. L., Johnson, D. W. (2013). Croup in children. Canadian Medical Association Journal, 185 (15), 1317–1323. doi: 10.1503/cmaj.121645

Bjornson, C., Russell, K. F., Vandermeer, B., Durec, T., Klassen, T. P., Johnson, D. W. (2011). Nebulized epinephrine for croup in children. Cochrane Database Syst Rev, 2. doi: 10.1002/14651858.cd006619.pub2

Russell, K. F., Liang, Y., O'Gorman, K., Johnson, D. W., Klassen, T. P. (2011). Glucocorticoids for croup. Cochrane Database Syst Rev, 1. doi: 10.1002/14651858.cd001955.pub3

Sparrow, A., Geelhoed, G. (2005). Prednisolone versus dexamethasone in croup: a randomised equivalence trial. Archives of Disease in Childhood, 91 (7), 580–583. doi: 10.1136/adc.2005.089516

Fifoot, A. A., Ting, J. Y. (2007). Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: A randomized, double-blinded clinical trial. Emergency Medicine Australasia, 19 (1), 51–58. doi: 10.1111/j.1742-6723.2006.00919.x

Chub-Uppakarn, S., Sangsupawanich, P. (2007). A randomized comparison of dexamethasone 0.15mg/kg versus 0.6mg/kg for the treatment of moderate to severe croup. International Journal of Pediatric Otorhinolaryngology, 71 (3), 473–477. doi: 10.1016/j.ijporl.2006.11.016

Bjornson, C. L., Klassen, T. P., Williamson, J., Brant, R., Mitton, C., Plint, A. et. al. (2004). A Randomized Trial of a Single Dose of Oral Dexamethasone for Mild Croup. New England Journal of Medicine, 351 (13), 1306–1313. doi: 10.1056/nejmoa033534

Çetinkaya, F., Tüfekçi, B. S., Kutluk, G. (2004). A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup. International Journal of Pediatric Otorhinolaryngology, 68 (4), 453–456. doi: 10.1016/j.ijporl.2003.11.017

Berezhnoi, V. V., Kozachuk, V. G., Glyadelova, N. P., Korneva, V. V., Koroleva, V. A., Lischinskaya, M. R. (2012). Sovremennyye aspekty terapii ostrogo stenoziruyushchego laringotrakheita u detey [Modern aspects of threatment of stenosing laryngotracheitis in children]. Sovremennaya pediatriya, 5, 57–61.

Carlsen, K. C. L., Stick, S., Kamin, W., Cirule, I., Hughes, S., Wixon, C. (2005). The efficacy and safety of fluticasone propionate in very young children with persistent asthma symptoms. Respiratory Medicine, 99 (11), 1393–1402. doi: 10.1016/j.rmed.2005.04.008

Adams, N. P., Bestall, J. C., Jones, P. W., Lasserson, T. J., Griffiths, B., Cates, C. (2008). Inhaled fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev, 4. doi: 10.1002/14651858.cd003534.pub3

Roorda, R. J., Walhof, C. M. (1998). Effects of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report., 25 (2), 114–117. doi: 10.1002/(sici)1099-0496(199802)25:2<114::aid-ppul7>3.0.co;2-n

Published

2015-08-20

Issue

Section

Medical